Special Issue "Dermatopathology and COVID-19"
A special issue of Dermatopathology (ISSN 2296-3529).
Deadline for manuscript submissions: 15 December 2022 | Viewed by 4847
2. Department of Clinical Pathology, University Hospital of Geneva, 1205 Geneva, Switzerland
Interests: molecular pathology of skin aging and dermatoporosis; clinicopathological correlation in inflammatory dermatoses; pathology of melanocytic lesions; molecular dermatopathology; dermatotoxicopathology
Special Issues, Collections and Topics in MDPI journals
With the growing number of cases with skin manifestations related to COVID-19, we have decided to dedicate a Special Issue to this subject. This Special Issue aims to cover these cutaneous lesions, which may be quite diverse. The major clinical forms described were maculopapular eruptions, acral areas of erythema with vesicles or pustules (pseudochilblain), urticarial lesions, other vesicular eruptions, and livedo or necrosis. The histopathological features of these lesions also vary, corresponding to the diversity of clinical manifestations. These features underline the nature of epidermal and dermal vascular lesions—and in severe cases, microvascular injury and thrombosis—associated with COVID-19 and provide important clues to their pathological mechanisms.
Prof. Dr. Gürkan Kaya
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Dermatopathology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- skin lesions
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: The Impact of COVID-19 Pandemic on Dermatological Conditions: A Comprehensive Review
Authors: Gehan A. Pendlebury; Peter Oro; William Haynes; Drew Merideth; Samantha Bartling; Michelle A. Bongiorno
1. Nova Southeastern University, College of Osteopathic Medicine, Fort Lauderdale, FL, USA
2. A.T. Still University, School of Osteopathic Medicine in Arizona, Mesa, AZ, USA
3. Department of Dermatology, Walter Reed National Military Medical Center, Bethesda, MD, USA
Abstract: Background: The earliest cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019. Since the declaration as a pandemic on March 11, 2020, further dermatological conditions continue to be documented. We herein present a novel literature review of dermatological manifestations associated with the Coronavirus Disease 2019 (COVID-19) pandemic. To date, this review is the first broad-spectrum COVID-19 literature review that examines a range of dermatological manifestations related to the COVID-19 pandemic: infection, vaccinations, personal protective equipment (PPE), and psychosocial factors. Methods: A detailed literature search was conducted using key terms for cutaneous manifestations associated with the scope of this review. The search retrieved 2,199 articles. Results: SARS-CoV-2 has been associated with dermatological conditions. One prominent mechanism describes viral spike protein invasion into the dermis by binding to the angiotensin-converting enzyme 2 (ACE-2) receptors in keratinocytes, with a secondary immunological response. The literature revealed a vast array of dermatoses associated with the pandemic: infection, vaccinations, personal protective equipment (PPE), and psychosocial factors. Conclusions: As dermatological manifestations emerge, dermatologists play an integral role in proper diagnosis and treatment. Early treatment regimens and prophylaxis may safely reduce infection-related dermatological sequelae. Additional investigations and data collection may reduce disease burden and improve disease prognosis.
Keywords: COVID-19; COVID-19 pandemic, SARS-CoV-2 infection; cutaneous manifestations; COVID arm; pandemic psychosocial stress; personal protective equipment; COVID vaccinations, psychodermatology, teledermatology